Trulieve Cannabis Corp.
TRLV· NYSE
TRLVTrulieve Cannabis Corp.
Quarterly figures for Trulieve Cannabis Corp., with source filings when available.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
Trulieve Cannabis Corp. has filed its 10-Q within 36 to 39 days of period end across its last 8 quarters. The 10-K runs 57 to 89 days.
Trulieve Cannabis Corp. · CIK 1754195 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 7, 2026 | 38 d | 10-Q | $270.95M | −10.3% | -$2.10 | |
| Mar 31, 2026 |
| May 7, 2026 · pre-market |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $286.75M |
| −3.7% |
| $0.02 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 26, 2026 · pre-market | Feb 26, 2026 | 57 d | 10-K | $293.15M | −2.7% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 5, 2025 · pre-market | Nov 5, 2025 | 36 d | 10-Q | $288.19M | +1.4% | -$0.11 | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · pre-market | Aug 6, 2025 | 37 d | 10-Q | $302.09M | −0.4% | -$0.07 | |
| Q1 2025 | Mar 31, 2025 | May 7, 2025 · pre-market | May 7, 2025 | 37 d | 10-Q | $297.76M | +0.0% | -$0.16 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 27, 2025 · pre-market | Feb 27, 2025 | 58 d | 10-K | $301.15M | +4.9% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 5, 2024 · pre-market | Nov 5, 2024 | 36 d | 10-Q | $284.28M | +3.3% | -$0.32 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · pre-market | Aug 6, 2024 | 37 d | 10-Q | $303.44M | +7.7% | -$0.04 | |
| Q1 2024 | Mar 31, 2024 | May 9, 2024 · pre-market | May 9, 2024 | 39 d | 10-Q | $297.62M | +4.3% | -$0.16 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 29, 2024 · pre-market | Feb 29, 2024 | 60 d | 10-K | $286.97M | −1.5% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · pre-market | Nov 9, 2023 | 40 d | 10-Q | $275.21M | −6.8% | -$0.12 | |
| Q2 2023 | Jun 30, 2023 | Aug 9, 2023 · pre-market | Aug 9, 2023 | 40 d | 10-Q | $281.80M | −10.2% | -$1.80 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · pre-market | May 10, 2023 | 40 d | 10-Q | $285.21M | −10.2% | -$0.18 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 8, 2023 · pre-market | Mar 8, 2023 | 67 d | 10-K | $291.29M | −2.5% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · after-hours | Nov 9, 2022 | 40 d | 10-Q | $295.35M | +31.8% | -$0.38 | |
| Q2 2022 | Jun 30, 2022 | Aug 10, 2022 · pre-market | Aug 10, 2022 | 41 d | 10-Q | $313.84M | +45.9% | -$0.09 | |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 · pre-market | May 12, 2022 | 42 d | 10-Q | $317.75M | +63.9% | -$0.16 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 30, 2022 · pre-market | Mar 30, 2022 | 89 d | 10-K | $298.90M | +77.5% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | $224.09M | +64.4% | $0.14 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 12, 2021 | 43 d | 10-Q | $215.12M | +78.1% | $0.31 | |
| Q1 2021 | Mar 31, 2021 | — | May 13, 2021 | 43 d | 10-Q | $193.82M | +101.8% | $0.24 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 23, 2021 | 82 d | 10-K | $168.44M | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $136.27M | — | $0.15 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $120.77M | — | $0.16 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $96.06M | — | $0.20 | |
